125 related articles for article (PubMed ID: 10774117)
1. [Cervix dysplasias: study of Rb and p53 gene expression and correlation with mitotic activity].
Mathevet P; Frappart L; Hittelman W
Gynecol Obstet Fertil; 2000 Jan; 28(1):44-50. PubMed ID: 10774117
[TBL] [Abstract][Full Text] [Related]
2. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract][Full Text] [Related]
3. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP
APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
[TBL] [Abstract][Full Text] [Related]
5. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.
Kuo KT; Chang HC; Hsiao CH; Lin MC
Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490
[TBL] [Abstract][Full Text] [Related]
6. Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesions.
Maeda MY; Simões M; Wakamatsu A; Longatto Filho AL; Oyafuso M; de Mello ES; Otta MM; Alves VA
Pathologica; 2001 Jun; 93(3):189-95. PubMed ID: 11433611
[TBL] [Abstract][Full Text] [Related]
7. p53 and human papilloma virus type 16 in cervical intraepithelial neoplasia and carcinoma.
ter Harmsel B; van Belkum A; Quint W; Pronk A; Kuijpers J; Ramaekers F; Tandon A; Smedts F
Int J Gynecol Pathol; 1995 Apr; 14(2):125-33. PubMed ID: 8601524
[TBL] [Abstract][Full Text] [Related]
8. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium.
Jeffers MD; Richmond J; Farquharson M; McNicol AM
J Clin Pathol; 1994 Dec; 47(12):1073-6. PubMed ID: 7876377
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium.
Shurbaji MS; Brooks SK; Thurmond TS
Am J Clin Pathol; 1993 Jul; 100(1):22-6. PubMed ID: 8102221
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
[TBL] [Abstract][Full Text] [Related]
12. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
[TBL] [Abstract][Full Text] [Related]
13. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix.
Vecchione A; Cermele C; Giovagnoli MR; Valli C; Alimandi M; Carico E; Esposito DL; Mariani-Costantini R; French D
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):343-8. PubMed ID: 7835772
[TBL] [Abstract][Full Text] [Related]
14. Proliferation cell nuclear antigen (PCNA) expression in cervical intraepithelial neoplasia (CIN). An immunohistochemical study.
Smela M; Chosia M; Domagała W
Pol J Pathol; 1996; 47(4):171-4. PubMed ID: 9097708
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer.
Fay J; Kelehan P; Lambkin H; Schwartz S
J Med Virol; 2009 May; 81(5):897-907. PubMed ID: 19319956
[TBL] [Abstract][Full Text] [Related]
16. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.
Wang JL; Zheng BY; Li XD; Angström T; Lindström MS; Wallin KL
Clin Cancer Res; 2004 Apr; 10(7):2407-14. PubMed ID: 15073118
[TBL] [Abstract][Full Text] [Related]
17. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
18. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia.
Herbsleb M; Knudsen UB; Orntoft TF; Bichel P; Norrild B; Knudsen A; Mogensen O
APMIS; 2001 Sep; 109(9):607-17. PubMed ID: 11878714
[TBL] [Abstract][Full Text] [Related]
20. Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
Balsitis S; Dick F; Dyson N; Lambert PF
Cancer Res; 2006 Oct; 66(19):9393-400. PubMed ID: 17018593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
